We're pleased to announce a decision to fund two new enteral liquid peptide formulas (Nutrini Peptisorb and Nutrini Peptisorb Energy) for use in children with impaired gastrointestinal (GI) function, from 1 September 2020 through an agreement with Nutricia Limited (Nutricia).

Nutrini Peptisorb and Nutrini Peptisorb Energy are nutritionally complete liquid peptide (semi-elemental) enteral feeds, designed for children with impaired GI function such as maldigestion or malabsorption, who do not tolerate a polymeric feed or for whom a polymeric feed may not be suitable. Both Nutrini Peptisorb and Nutrini Peptisorb Energy can be administered via naso-enteric tube, gastrostomy or jejunostomy.

We estimate that approximately 12 children per year will benefit from the listing of Nutrini Peptisorb and Nutrini Peptisorb Energy.

Any changes to the original proposal

This decision was subject to a consultation letter dated 21 July 2020.

No changes were made to the proposal following consultation feedback.

Who we think will be most interested

Parents and whnau of children with impaired GI function

Community and hospital dietitians

Paediatricians, paediatric gastroenterologists, paediatric surgeons, general practitioners, pharmacists and other clinicians and health professionals involved in the management of children with impaired GI function

Pharmaceutical suppliers and wholesalers

Contact:

Tel: 021 863 342

Email: media@pharmac.govt.nz

(C) 2020 Electronic News Publishing, source ENP Newswire